You searched for "blepharitis"
Théa launches new, free educational platform!
Théa Pharmaceuticals is excited to announce the launch of the Théa Academy, a dedicated platform supporting the education of eye health professionals across the UK.
Allergic eyelid dermatitis
This is a retrospective 12 year review of 61 patients diagnosed with periocular allergic dermatitis. The average age was 66 years, with 74% being female. The commonest indications for referral were epiphora, ectropion and blepharitis; and the main symptoms were...
Oral azithromycin for meibomian gland disease
Oral tetracyclines have been the traditional systemic treatment of blepharitis and acne rosacea, through inhibiting bacterial lipase production and reducing fatty acids. However, tetracyclines have a number of adverse side-effects and are required to be taken for a long duration...Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.Oct/Nov 2016 Quiz
History A 67-year-old female patient had chronic left canaliculitis becoming painful and more recently complicated by left lower blepharitis. Examination revealed a small fleshy lump on the medial aspect of the left lower eyelid. There was also swelling of the...
Lower postoperative scar height is associated with increased postoperative trichiasis one year after bilamellar tarsal rotation surgery
Bilamellar tarsal rotation has been a key component of the WHO SAFE approach to blindness from trichiaisis (surgery, antibiotics, facial hygiene, environment). The World Health Organisation (WHO) manual describes the procedure as a full thickness blepharotomy placed 3.0mm above and...
Long-term meibomian gland function following a single thermal pulsation treatment
Dry eyes secondary to blepharitis and or meibomian gland dysfunction, though extremely common, is an annoyingly difficult condition to treat for several patients. Part of this difficulty lies in the inability of most patients to follow intensive and often times...New cataract, cornea and ocular surface disease innovations from Kestrel Ophthalmics
Kestrel Ophthalmics, (a Cutting Edge company) is pleased to introduce an integrated medical and surgical approach to treat a range of conditions.Altacor add new products to the trusted Clinitas® brand family
Altacor are pleased to announce the launch of two new products. The range has now been expanded to include 0.2% preservative free sodium hyaluronate options to treat mild to moderate dry eye, sitting alongside our existing Clinitas 0.4% products for treating moderate to severe dry eye.Scope unveils newly rebranded VitA-POS as HYLO NIGHT® with all of the same features and benefits, but now under the trusted HYLO brand of ocular lubricants
SCOPE is pleased to announce the launch of its new night-time dry eye ointment HYLO-NIGHT® (formerly VitA-POS).
